Vivosim Labs Inc Asset Turnover Ratio (VIVS), as of first quarter 2026, current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Vivosim Labs Inc   (NASDAQ: VIVS)
 

Vivosim Labs Inc Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

Vivosim Labs Inc 's asset turnover ratio has remained unchanged compare to previous quarter at 0.01 in the first quarter (Jun 30 2026)

Within sector 76 more businesses have achieved higher asset turnover ratio. While ranking the asset turnover ratio, among all other companies, it is fair to say, that the company's position has deteriorated in the First Quarter 2026 compared to the preceding quarter from 3923 to 4343.

Asset Turnover Ratio Definition


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

VIVS Asset Turnover Ratio (Jun 30 2026)
I. Quarter		 (Mar 31 2026)
IV. Quarter		 (Dec 31 2025)
III. Quarter		 (Sep 30 2025)
II. Quarter		 (Jun 30 2025)
I. Quarter
Y / Y Asset Change -68.05 % -48.5 % 129.17 % 56.43 % 35.55 %
Y / Y Revenue Change -51.35 % -21.57 % 8.33 % -6.67 % -5.13 %
Asset Turnover Ratio (TTM) 0.01 0.01 0.01 0.01 0.01
VIVS's Total Ranking # 4343 # 3923 # 3985 # 4019 #
Seq. Asset Change -48.66 % -48.5 % 46.98 % -17.8 % -17.24 %
Seq. Revenue Change -55 % 53.85 % -7.14 % -24.32 % -27.45 %



Asset Turnover Ratio Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 77
Healthcare Sector # 610
Overall Market # 4343

Asset Turnover Ratio Statistics
High Average Low
0.08 0.04 0.01
(Jun 30 2018)   (Jun 30 2014)




VIVS Company Profile • Back to VIVS Efficiency Comparisons • Compare VIVS Asset Turnover Ratio to its Competitors



Companies with similar Asset Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Jun 30 2026 Assets at quarter ending Jun 30 2026
Lipocine Inc   0.08 $ 1.569  Millions$ 20.568  Millions
Catheter Precision Inc   0.07 $ 1.915  Millions$ 28.322  Millions
Metagenomi Therapeutics Inc   0.06 $ 13.561  Millions$ 209.924  Millions
Nurix Therapeutics Inc   0.06 $ 36.766  Millions$ 595.569  Millions
Ispecimen inc   0.06 $ 0.466  Millions$ 8.133  Millions
Prophase Labs Inc   0.05 $ 3.150  Millions$ 60.428  Millions
Insight Molecular Diagnostics Inc   0.05 $ 1.670  Millions$ 34.891  Millions
Agape Atp Corporation  0.05 $ 1.152  Millions$ 24.729  Millions
Vistagen Therapeutics Inc   0.04 $ 2.501  Millions$ 62.393  Millions
Northwest Biotherapeutics Inc  0.03 $ 2.173  Millions$ 66.973  Millions
Dbv Technologies S a   0.02 $ 5.018  Millions$ 223.351  Millions
Vivosim Labs Inc   0.01 $ 0.112  Millions$ 8.892  Millions
Envoy Medical Inc   0.01 $ 0.207  Millions$ 17.628  Millions
Bellevue Life Sciences Acquisition Corp  0.01 $ 1.809  Millions$ 171.835  Millions
Sharps Technology Inc   0.01 $ 2.468  Millions$ 263.597  Millions
Clene Inc   0.01 $ 0.197  Millions$ 21.287  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.